Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating buprenorphine for analgesic opioid dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED